The valuations are just to compelling
CVS is a great Co. As for a return Institutions filing show a shift to RAD from CVS. It's not and all in but just starter positions. I'm still holding some CVS.
Filing today confirm more of this move.
More upgrades on RAD $1.59 based on compiling valuation compared to CVS $51. RAD is 1/10 the valuation plus analyst smart money managers 2013 predict RAD to Triple with a price target of $3.20